A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region
Part of paid clinical trials in Macon, Georgia.
- Sponsor
- Organon and Co
- Study ID
- NCT05789576
- Phase
- PHASE4
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- VTAMA (tapinarof) cream, 1% — DRUGVTAMA (tapinarof) cream, 1% applied topically once daily
Study Details
This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with plaque psoriasis occurring in the head and neck region
Key Dates
- Start date
- Mar 13, 2023
- Status verified
- Aug 2024
- Primary completion
- Jun 30, 2023
- Completion
- Jul 19, 2023
Study Design
- Enrollment
- 31 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: VTAMA (tapinarof) cream, 1%VTAMA (tapinarof) cream, 1% applied topically once daily
Primary Outcome Measure
Percentage of Participants Who Achieve a Target Lesion Physician Global Assessment (PGA) Score in the Head and Neck Region of Clear (0) or Almost Clear (1) With a ≥ 2-grade Improvement [ Time Frame: from Baseline to Week 12 ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dermavant Investigative Site | Macon | Georgia | 31217 | - |
| Dermavant Investigative Site | Chicago | Illinois | 60602 | - |
| Dermavant Investigative Sites | Rockville | Maryland | 20850 | - |
| Dermavant Investigative Site | Auburn Hills | Michigan | 48326 | - |
| Dermavant Investigative Site | Detroit | Michigan | 48202 | - |
| Dermavant Investigative Site | Las Vegas | Nevada | 89144 | - |
| Dermavant Investigative Site | Portsmouth | New Hampshire | 03801 | - |
| Dermavant Investigative Site | Kew Gardens | New York | 11415 | - |
| Dermavant Investigative Site | Marion | Ohio | 43302 | - |
| Dermavant Investigative Site | Arlington | Texas | 76014 | - |
Find similar trials in Macon, GA
By condition
By specialty
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland